Volume 35, No 9, Sep 2025

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 35 Issue 9, September 2025: 687-690   |  Open Access

LETTERS TO THE EDITOR

Differentiation therapy with hepatocyte nuclear factor 4α for patients with hepatocellular carcinoma

Chuan Yin^1,† , Wen-Ping Xu^1,† , Wei-Hua Dong^2,† , Chen-Hong Ding^1,† , Jia-Rong Cai¹ , Xin Zeng³ , Si-Han Wu¹ , Pei-Mei Shi¹ , Xin Zhang^1,* , Wei-Fen Xie^1,*

¹Department of Gastroenterology, Changzheng Hospital, Naval Medical University, Shanghai, China
²Department of Interventional Radiology, Changzheng Hospital, Naval Medical University, Shanghai, China
³Department of Gastroenterology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
^†These authors contributed equally: Chuan Yin, Wen-Ping Xu, WeiHua Dong, Chen-Hong Ding
Correspondence: Xin Zhang(zhang68@hotmail.com)Wei-Fen Xie(weifenxie@medmail.com.cn)

https://doi.org/10.1038/s41422-025-01142-3

FULL TEXT | PDF

Browse 125